🇺🇸 FDA
Patent

US 10077271

Methods and compositions for inhibiting the interaction of menin with MLL proteins

granted A61PA61P3/10A61P35/00

Quick answer

US patent 10077271 (Methods and compositions for inhibiting the interaction of menin with MLL proteins) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Sep 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61P, A61P3/10, A61P35/00, A61P35/02, A61P35/04